HIV/HCV coinfection exacerbates ESLD risk

摘要

Patients coinfected with HIV and hepatitis C virus (HCV) are more likely to develop end-stage liver disease (ESLD) compared to patients who are HCV-monoinfected, according to a study presented by French researchers at the XVI International AIDS Conference held August 13-18, 2006, in Toronto. However, the researchers found that HIV/HCV-coin-fected patients who achieved a sustained virological response to hepatitis C therapy were no more likely to progress to ESLD than their HCV-monoinfected peers.